Chinese Traditional and Herbal Drugs
|
2025, 56(24): 9172-9184
Research progress on bidirectional regulatory mechanism and Chinese and Western medicine treatment of depression in pulmonary diseases
Full
SUN Lehua1,2, QIN Xuemei1,2, LIU Xiaojie1,2
Affiliations
1 Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China;
2 The Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, Shanxi University, Taiyuan 030006, China
doi: 10.7501/j.issn.0253-2670.2025.24.027
Outline
The comorbidity of pulmonary diseases and depression exhibits a bidirectional pathological relationship, forming a vicious cycle that is difficult to break and posing a significant challenge in clinical treatment. The mechanisms underlying this comorbidity not only align with the “neuro-immune-microecological” imbalance theory proposed by modern medicine but also are highly correspond with the holistic concept of “Zang-Fu correlation” in traditional Chinese medicine (TCM). On one hand, factors such as pulmonary-derived inflammatory cytokine storms, hypoxic stress, and abnormal activation of the hypothalamic-pituitary-adrenal axis can lead to dysregulated expression of neurotransmitters and neurogenic factors, mediating inflammatory cascades via the “lung-brain axis” and thereby inducing or exacerbating depressive states. On the other hand, autonomic dysfunction associated with depression can further impair pulmonary function, creating a feedback loop that aggravates the condition. Additionally, microecological imbalances triggered by the comorbid state facilitate the spread of pathological signaling networks across organs through multi-visceral interactions such as the “lung-brain axis” and “lung-brain-gut axis”, resulting in a complex interplay between “disease-induced depression” and “depression-induced disease”, which contributes to disease chronicity and treatment resistance. In terms of treatment, Western medicine, while target-specific, often presents notable side effects, whereas TCM emphasizes holistic regulation and multi-target intervention. The combination of both approaches leverages their complementary advantages and synergistic effects, demonstrating broad prospects in the management of this comorbidity. Future efforts should focus on establishing an interdisciplinary integrated research paradigm, incorporating multi-dimensional biological information to develop personalized precision diagnosis and treatment systems, and employing dynamic modeling methods to continuously optimize therapeutic pathways, ultimately achieving comprehensive improvements in clinical efficacy and patient quality of life.
pulmonary system diseases
/
depression
/
pulmonary encephalopathy
/
lung-brain axis
/
interaction mechanisms
/
integrated therapy of traditional Chinese and Western medicines
孙乐华, 秦雪梅, 刘晓节.
肺系疾病共病抑郁的双向调控机制及中西药治疗研究进展.
中草药,
2025
, 56
(24)
: 9172
-9184
.
DOI: 10.7501/j.issn.0253-2670.2025.24.027
SUN Lehua, QIN Xuemei, LIU Xiaojie.
Research progress on bidirectional regulatory mechanism and Chinese and Western medicine treatment of depression in pulmonary diseases[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(24)
: 9172
-9184
.
DOI: 10.7501/j.issn.0253-2670.2025.24.027
Year 2025 volume 56 Issue 24
48
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.24.027
- Receive Date:2025-06-16
- Online Date:2026-11-13